Removal of draft wording in the directors report HY accounts
Filed with ASX · · 22 pages · English
Summary by 6ix AI
The company identified an error in the draft wording included in the directors' report and has attached a corrected version of the report. No other changes were made to the accounts, which have been redated accordingly along with the auditor's independence declaration and audit report.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- Half Yearly Report and Accounts
- Jun26 Appendix 4C Cash Flow Report
- Jun26 Quarterly Activities Report
- Change in substantial holding
- Update on Funding Facility and Clinical Program
Later from Nexalis Therapeutics
- Chair Appointment/Resignation
- Initial Director's Interest Notice - Niv Dagan
- Final Director's Interest Notice - Sean Williams
- Change of Director's Interest Notice - Darryl Davies
- Notification of cessation of securities - NX1
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics